Amgen Inc.
VEGFR-FC FUSION PROTEIN FORMULATIONS

Last updated:

Abstract:

VEGFR-Fc fusion protein formulations and methods of making using such formulations are provided herein. In one embodiment, the formulation is an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the VEG-FR-Fc fusion protein is aflibercept.

Status:
Application
Type:

Utility

Filling date:

17 Sep 2018

Issue date:

13 Aug 2020